If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

Share Price is delayed by 15 minutes
Get Live Data
110.50    -3.35 (-2.94%)
Bid:
110.60
Ask:
110.65
Spread: 0.05 (0.045%)
Market Cap: £64.26b
LLOY Live PriceLast checked at - London Stock Exchange

Intraday Lloyds Share Chart

Notification of Redemption

29 Jul 2025 18:11

RNS Number : 0751T
Lloyds Banking Group PLC
29 July 2025
 

 

Lloyds Banking Group plc

 

Redemption of the Outstanding $1,500,000,000 7.5 per cent Fixed Rate Reset Additional Tier 1 Perpetual Subordinated Contingent Convertible Securities

(ISIN: US539439AU36 / CUSIP: 539439AU3)

 

 

July 29, 2025. Lloyds Banking Group plc (the "Group") announces that it has issued a notice of redemption for the entire outstanding principal amount of its $1,500,000,000 7.5 per cent Fixed Rate Reset Additional Tier 1 Perpetual Subordinated Contingent Convertible Securities (the "Notes"). A notice of redemption pursuant to Section 2.12 Notice of Redemption of the Second Supplemental Indenture dated October 10, 2018 governing the Securities has been distributed to The Bank of New York Mellon, acting through its London Branch, as trustee (the "Trustee").

 

The outstanding Notes will be redeemed on September 29, 2025 (the "Redemption Date") at an amount equal to 100% of their principal amount, together with any accrued but unpaid interest to, but excluding, the Redemption Date (the "Redemption Price"). Accordingly, the listing of the Notes on the Global Exchange Market of the Irish Stock Exchange will be cancelled on, or shortly after, September 29, 2025.

 

The location where Holders may surrender the Notes and obtain payment of the Redemption Price is The Bank of New York Mellon, 160 Queen Victoria Street. London EC4V 4LA

Attn: Corporate Trust Administration, Email: corpsov4@bnymellon.com

 

On the Redemption Date, the Redemption Price will become due and payable and interest on the Notes will cease to accrue. Before the Redemption Date, the Group will irrevocably deposit with the Trustee or with a paying agent an amount of money sufficient to pay the total Redemption Price of each of the Notes. When the Group makes such a deposit, all rights of the holders of the Notes will cease, except the holders' rights to receive the Redemption Price and the Notes will no longer be outstanding.

 

For further information in relation to the redemption of the Notes, please contact:

 

Group Corporate Treasury:

 

Kris MiddletonHead of Term Issuance and Capital StructuringTelephone: +44 (0)207 356 1122

 

Niamh O'Connor

Head of Debt Investor Relations

Telephone: +44 (0)7350 418011

 

* This CUSIP number has been assigned to this issue by a third party, and is included solely for the convenience of the holders of the Notes. Neither the Group nor the Trustee shall be responsible for the selection or use of this CUSIP number, nor is any representation made as to its correctness on the Notes or as indicated in any redemption notice.

 

 

 

 

 

 

 

Forward Looking Statements

This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and section 27A of the US Securities Act of 1933, as amended, with respect to the business, strategy, plans and/or results of Lloyds Banking Group plc together with its subsidiaries (the Group) and its current goals and expectations. Statements that are not historical or current facts, including statements about the Group's or its directors' and/or management's beliefs and expectations, are forward-looking statements. Words such as, without limitation, 'believes', 'achieves', 'anticipates', 'estimates', 'expects', 'targets', 'should', 'intends', 'aims', 'projects', 'plans', 'potential', 'will', 'would', 'could', 'considered', 'likely', 'may', 'seek', 'estimate', 'probability', 'goal', 'objective', 'deliver', 'endeavour', 'prospects', 'optimistic' and similar expressions or variations on these expressions are intended to identify forward-looking statements. These statements concern or may affect future matters, including but not limited to: projections or expectations of the Group's future financial position, including profit attributable to shareholders, provisions, economic profit, dividends, capital structure, portfolios, net interest margin, capital ratios, liquidity, risk-weighted assets (RWAs), expenditures or any other financial items or ratios; litigation, regulatory and governmental investigations; the Group's future financial performance; the level and extent of future impairments and write-downs; the Group's ESG targets and/or commitments; statements of plans, objectives or goals of the Group or its management and other statements that are not historical fact and statements of assumptions underlying such statements. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend upon circumstances that will or may occur in the future. Factors that could cause actual business, strategy, targets, plans and/or results (including but not limited to the payment of dividends) to differ materially from forward-looking statements include, but are not limited to: general economic and business conditions in the UK and internationally (including in relation to tariffs); imposed and threatened tariffs and changes to global trade policies; acts of hostility or terrorism and responses to those acts, or other such events; geopolitical unpredictability; the war between Russia and Ukraine; the escalation of conflicts in the Middle East; the tensions between China and Taiwan; political instability including as a result of any UK general election; market related risks, trends and developments; changes in client and consumer behaviour and demand; exposure to counterparty risk; the ability to access sufficient sources of capital, liquidity and funding when required; changes to the Group's credit ratings; fluctuations in interest rates, inflation, exchange rates, stock markets and currencies; volatility in credit markets; volatility in the price of the Group's securities; natural pandemic and other disasters; risks concerning borrower and counterparty credit quality; risks affecting insurance business and defined benefit pension schemes; changes in laws, regulations, practices and accounting standards or taxation; changes to regulatory capital or liquidity requirements and similar contingencies; the policies and actions of governmental or regulatory authorities or courts together with any resulting impact on the future structure of the Group; risks associated with the Group's compliance with a wide range of laws and regulations; assessment related to resolution planning requirements; risks related to regulatory actions which may be taken in the event of a bank or Group failure; exposure to legal, regulatory or competition proceedings, investigations or complaints; failure to comply with anti-money laundering, counter terrorist financing, anti-bribery and sanctions regulations; failure to prevent or detect any illegal or improper activities; operational risks including risks as a result of the failure of third party suppliers; conduct risk; technological changes and risks to the security of IT and operational infrastructure, systems, data and information resulting from increased threat of cyber and other attacks; technological failure; inadequate or failed internal or external processes or systems; risks relating to ESG matters, such as climate change (and achieving climate change ambitions) and decarbonisation, including the Group's ability along with the government and other stakeholders to measure, manage and mitigate the impacts of climate change effectively, and human rights issues; the impact of competitive conditions; failure to attract, retain and develop high calibre talent; the ability to achieve strategic objectives; the ability to derive cost savings and other benefits including, but without limitation, as a result of any acquisitions, disposals and other strategic transactions; inability to capture accurately the expected value from acquisitions; assumptions and estimates that form the basis of the Group's financial statements; and potential changes in dividend policy. A number of these influences and factors are beyond the Group's control. Please refer to the latest Annual Report on Form 20-F filed by Lloyds Banking Group plc with the US Securities and Exchange Commission (the SEC), which is available on the SEC's website at www.sec.gov, for a discussion of certain factors and risks. Lloyds Banking Group plc may also make or disclose written and/or oral forward-looking statements in other written materials and in oral statements made by the directors, officers or employees of Lloyds Banking Group plc to third parties, including financial analysts. Except as required by any applicable law or regulation, the forward-looking statements contained in this document are made as of today's date, and the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this document whether as a result of new information, future events or otherwise. The information, statements and opinions contained in this document do not constitute a public offer under any applicable law or an offer to sell any securities or financial instruments or any advice or recommendation with respect to such securities or financial instruments.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRGDRLGDDGUC
Date   Source Headline
23rd Feb 20236:07 pmRNSTransaction in Own Shares
23rd Feb 20237:00 amRNSShare Buyback Programme Commences
22nd Feb 202311:38 amRNSPublication of Suppl.Prospcts
22nd Feb 20237:00 amRNS2022 Annual Report and Accounts
22nd Feb 20237:00 amRNS2022 Full Year Results
10th Feb 20235:00 pmRNSDirector/PDMR Shareholding
31st Jan 20234:57 pmRNSTotal Voting Rights
11th Jan 20232:36 pmRNSPublication of Final Terms
11th Jan 20232:15 pmRNSDirector/PDMR Shareholding
3rd Jan 202310:00 amRNSBlock listing Interim Review
3rd Jan 20237:00 amRNSTotal Voting Rights
16th Dec 20224:36 pmRNSDirector/PDMR Shareholding
12th Dec 20224:09 pmRNSDirector/PDMR Shareholding
7th Dec 20222:00 pmRNSBlock Listing of Shares
1st Dec 20229:57 amRNSDirector/PDMR Shareholding
30th Nov 20223:31 pmRNSTotal Voting Rights
16th Nov 20224:30 pmRNSDirector/PDMR Shareholding
10th Nov 20223:30 pmRNSDirector/PDMR Shareholding
1st Nov 20229:43 amRNSDirector Declaration
31st Oct 20222:18 pmRNSTotal Voting Rights
27th Oct 202212:07 pmRNSPublication of Supplementary Prospectus
27th Oct 202212:01 pmRNS2022 Q3 Interim Management Statement
27th Oct 20227:00 amRNS2022 Q3 Interim Management Statement
12th Oct 20222:00 pmRNSDirector/PDMR Shareholding
12th Oct 20227:00 amRNSLBG COMPLETES SHARE BUYBACK PROGRAMME
11th Oct 20225:27 pmRNSTransaction in Own Shares
11th Oct 20229:06 amRNSLBG ANNOUNCES RESULTS OF TENDER OFFER
10th Oct 20225:39 pmRNSTransaction in Own Shares
7th Oct 20225:49 pmRNSTransaction in Own Shares
6th Oct 20225:46 pmRNSTransaction in Own Shares
5th Oct 20225:42 pmRNSTransaction in Own Shares
4th Oct 20225:46 pmRNSTransaction in Own Shares
3rd Oct 20225:11 pmRNSTransaction in Own Shares
30th Sep 20225:58 pmRNSTransaction in Own Shares
30th Sep 20224:09 pmRNSTotal Voting Rights
30th Sep 20222:00 pmRNSDirector/PDMR Shareholding
30th Sep 202210:00 amRNSDirectorate Change
29th Sep 20225:29 pmRNSTransaction in Own Shares
28th Sep 20225:39 pmRNSTransaction in Own Shares
27th Sep 20225:22 pmRNSTransaction in Own Shares
26th Sep 20225:36 pmRNSTransaction in Own Shares
23rd Sep 20225:40 pmRNSTransaction in Own Shares
23rd Sep 202212:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20229:18 amRNSNotice of Redemption
22nd Sep 20225:43 pmRNSTransaction in Own Shares
22nd Sep 20224:02 pmRNSDirector/PDMR Shareholding
21st Sep 20225:31 pmRNSTransaction in Own Shares
20th Sep 20225:22 pmRNSTransaction in Own Shares
16th Sep 20226:10 pmRNSTransaction in Own Shares
16th Sep 20221:47 pmRNS2022 Half-Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.